Provides financial leadership with structure, discipline, and controls to accounting processes surrounding cash management, disbursements, and financial reporting; drives daily, weekly, and monthly cash management controls; Maximizes and develops system processes to utilize the Company’s investment in SAP, the ERP system; Developed and maintains the financial reporting process to the Company’s lenders, management and investor group. - Constructed improvement in the financial closing process to a 9 day close, which includes implementing controls around journal entry approval; developed full balance sheet reconciliation process reviewed and approved by CFO; engineered and developed 15 Crystal Reports to streamline the closing processes for Accounts Payable, Accounts Receivable and Inventory. - After the SAP conversion and during the financial reconciliation development, the entire balance sheet accounts were scrubbed which resulted in removing $800K of over stated Liabilities due to an SAP conversion process around receiving without a purchase order. - Incorporated Quick Books, legacy system with SAP financial data to simplify financial reporting to Company’s management and investment group, and the lenders, which met every financial due date. - Constructed weekly disbursement process controlled by management review and final approval by CFO.

Provided financial leadership, drove cash management, developed and improved financial reporting, planning and compliance; Day to day management responsibilities for overseeing cash management, financial analysis, and re-forecasting; Coordinated and developed semi-annual forecast and strategic plans adhering to all corporate requirements and deadlines; Analyzed revenue activity while providing recommendations to the practice group leaders to meet the financial obligations the firm had projected. - Created 13-week cash projection to minimize cash fluctuations. - Developed and maintained Financial Operations Summary report comparing cash received and disbursements. - Revamped the monthly financial reporting package, which incorporate hour and financial metrics. - Improved the financial closing process to 9 days.

Job Description• Cash Management including reporting daily cash balances, update monthly cash projection for cash receipts and disbursements, and report weekly cash balances summarizing cash receipts and disbursements, while providing explanations for actual differences from expectations.• Revenue Recognition responsibilities include Gross Revenue to Net Revenue Accruals, based on contractual agreements with direct customers, indirect customers, and the Government. Maintain and review processed documentation to ensure Gross Revenue to Net Revenue percentages by customer is contractually accurate. Review Gross Revenue to Net Revenue percentages is accurate for estimated accruals at the point of sale. • Supervise Financial Operations Staff including Accounts Receivable activities including New Customer setup, daily sales reporting, managing external inventory processor, and reconciliations. Accounts Payable activities including Authority, Concur, Corporate Cards, Fleet expenses, 1099, Sunshine Act reporting, disbursements, and reconciliations. Inventory and Fixed Asset transactions and reconciliations.• Maintain Crystal Reports for Financial Reporting, which include Balance Sheets, Income Statements, Trial Balances, Product Financial Statements, and more.• JD Edwards Financial Transaction Review and Maintenance for all JD Edwards modules.• Review Government Price Reporting Calculations.• Provide Guidance on Annual Budget and Quarterly Re-Forecasting.Financial Highlights• Orchestrated another new JD Edwards environment after Lumara's board of directors announced Lumara Health Inc. was sold to AMAG Pharmaceuticals in early October, 2014.• Financial team lead for the company name change from KV Pharmaceuticals/TherRx Corporation to Lumara Health Inc. in July, 2014.• Financial team lead for developing a new JD Edwards environment that will sustain the financial needs for KV Pharmaceutical/TherRx Corporation, which existed bankruptcy on September 16, 2013.

Job Description• Cash Management including reporting daily cash balances, update monthly cash projection for cash receipts and disbursements, and report weekly cash balances summarizing cash receipts and disbursements, while providing explanations for actual differences from expectations.• Revenue Recognition responsibilities include Gross Revenue to Net Revenue Accruals, based on contractual agreements with direct customers, indirect customers, and the Government. Maintain and review processed documentation to ensure Gross Revenue to Net Revenue percentages by customer is contractually accurate. Review Gross Revenue to Net Revenue percentages is accurate for estimated accruals at the point of sale. • Supervised Financial Operations Staff in Accounts Receivable, Accounts Payable, Inventory,Fixed Asset transactions and reconciliations.• Maintained Crystal Reports for Financial Reporting, which included Balance Sheets, Income Statements, Trial Balances, Product Financial Statements, and more.• JD Edwards Financial Transaction Review and Maintenance for all JD Edwards modules.• Reviewed Government Price Reporting Calculations.• Provided Guidance on Annual Budget and Quarterly Re-Forecasting.Financial Highlights• In August, 2012, instrumental analyzing cash balances prior to filing for bankruptcy, prepared schedule F documents, maintained weekly cash reporting and monthly cash projections to court.• Absorbed Financial Operations department after headcount reductions in January, 2012.• Re-engineered the revenue recognition accruals for the branded division in March, 2011 during the Makena product launch.• Instrumental developing accounting processes for the authorized generic division, Nesher Pharmaceuticals, which was sold in August, 2011.• Led the Finance group through the sale process of the specialty pharmaceutical division, PDI, in June, 2010.

Job Description• Provide Financial analytic by product to generic division and corporate management surrounding the annual budget, monthly financials, and weekly forecasts.• Revenue Recognition responsibilities include Gross Revenue to Net Revenue Accruals, based on contractual agreements with direct customers, indirect customers, and the Government. Maintain and review processed documentation to ensure Gross Revenue to Net Revenue percentages by customer is contractually accurate. Review Gross Revenue to Net Revenue percentages is accurate for estimated accruals at the point of sale. • Maintained Crystal Reports for Financial Reporting, which included Balance Sheets, Income Statements, Trial Balances, Product Financial Statements, and more.• JD Edwards Financial Transaction Review and Maintenance for all JD Edwards modules.• Reviewed Government Price Reporting Calculations.Financial Highlights• Due to the consent decree, developed the reserves for product recall costs, processing fees,failure to supply accruals for approximately 190 products for a combined total in excess of $87 million. The reserves were within 5% of the original estimate and never required an adjustment after four years.• Orchestrated the forecast and allowance accruals for three major product launches: o Oxycodone ER in October, 2009 o Metoprolol ER in July, 2007 o Diltiazem in September, 2006 • Initiated, developed, and programmed a Crystal report, which reported entire generic division inventory by lot based upon transactions recorded in JD Edwards. The report detailed time spent in manufacturing, quality assurance, quality control, and months to sell.• Developed and maintained a monthly management report which summarized product reporting by individual products, product family, and therapeutic family. The report package included a balance sheet, income statement, product price/volume, inventory turns and more.

• Engineered the process flow and drove the implementation to upload the financial model, which contains sales and expense detail, into JD Edwards. The Financial Planning group can easily report on specific company activities, consolidate multiple companies, intermingle actual and forecast data to determine the company’s path, which can be updated weekly or monthly.• Developed a sound financial model to forecast/budget/analyze complex gross-to-net allowances used within the generic pharmaceutical business environment. The model is built on individual NDC information by estimating sales in market channels, pricing, and estimating gross-to-net percentages based upon actual data. The model provides monthly, quarterly information, while summarizing product NDC detail into product family and therapeutic family totals. • Re-engineered a government pricing calculation to utilize actual transactions from multiple systems to be summarized by product NDC data, which is then used to perform detail calculations for government report. The government pricing calculation used the Crystal Reports software to summarize files from JD Edwards and I-Many to perform the calculation, while allowing for easy general ledger reconciliation. The calculation was used as the basis for the recent DRA calculation, which was established in October, 2007 and is still used today.

• Managed, trained, and provided corporate wide assistance for all the financial business system enhancements relating to the JD Edwards system. Extensive proficiency with JD Edwards FASTR financial reports, and world writer brought about company wide efficiency on reporting financial results weekly, monthly, quarterly, and annually. • Created report packages for all company managers detailing revenue and expenses. • Initiated, developed, and completed several vendor interface modules into JD Edwards’s system, included ADP payroll processing, sales representative expense check reimbursements, and an extensive lease car fleet invoice through EDI transactions.

• Management, organizational, and development skills were instrumental during the JD Edwards yearlong installation project at KV Pharmaceutical. Extensive computer knowledge allowed for an easy transition to JD Edwards modules including general ledger, accounts payable, accounts receivable, and customer conversions. Orchestrated the installation, verification, and maintenance of the automatic accounting instructions, which performs all journal entries throughout the entire JD Edwards system. • Met corporate installation objectives for the financial module installation. Converted three general ledger years from previous financial system. Provided desk top procedural documentation for all financial operating functions. • Led the JD Edwards sales module installation. Developed the advanced pricing module to automatically establish sales accruals at the point of sale by product. Engineered the entire credit memo process that allows for product and customer financial statements to be generated.

• Maintained general ledger and consolidated financial statements. Responsible for quarterly and annual work papers for generic and branded business. Excelled as the computer liaison between finance and business information systems group. • Instrumental in converting parent company into the Vanguard system, a mainframe software program, which incorporated all business activities. Influential in system development for general ledger, financial reporting, sales organization, accounts payable, and accounts receivable.• Developed customer and product financial statements for the generic and branded businesses, which reported on individual NDC’s, products, and therapeutic product families.

• Maintained ETHEX’s general ledger and financial statements. Responsible for quarterly and annual work papers for ETHEX generic division. • Initiated, developed, and programmed the sales division accrual and payment schedules by product and customer. Payments include various discounted accruals calculated by product and customer either monthly or quarterly. • Developed and maintained a research reporting system that tracked 200 projects, which identified $250k in reimbursable expenses in the first year.

• Responsible for automating and maintaining financial systems focused on improving efficiency, upgrading quality and timeliness of month-end financial reporting, forecasting, and analyzing key business indicators. • Automated the loan loss reserve audit, which surfaced a $3 billion dollar discrepancy and caused a six month recalculation. • Developed an automated process that identified good loans in non-interest bearing investors and transferred the loans into a profitable investor, which resulted in an average $84k savings per month.